Scholars Central

Research articlePublished 12 Sep 2023

HBV Integration Affects the Efficacy of Systemic Drug Therapy after Radical Resection of Liver Cancer: A Prospective Cohort Study

Authors: Zixiong Li, Chao Chen, Anfeng Si, Wenshu Qu, Jue Zhang, Huiyu Li, Zhaojun Xia, Linhua Luo, Yuanjing Zhang, Xiufeng Liu

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Hepatitis B Virus (HBV) gene integration is an important factor in the occurrence and development of HBV-Hepatocellular Carcinoma (HBV-HCC); however, its role in the clinical treatment of liver cancer is still unclear. This study aimed to investigate the effect of HBV integration on the prognosis of patients. Method: Twenty patients with HBV-HCC were included based on strict inclusion criteria. Whole genome sequencing of HBV-HCC surgical specimens was performed to identify HBV gene integration events. After systemic drug treatment (tyrosine kinase inhibitors alone or in combination with immune checkpoint inhibitors), the therapeutic efficacy was evaluated based on RECIST 1.1 criteria. COX regression model was used to identify factors affecting Progression-Free Survival (PFS) and Overall Survival (OS). Results: HCC tissue samples from 20 HBV-HCC patients were sequenced and matched with standard sequence. HBV integration was found in 10 out of the 20 patients. The highest frequency of HBV integration occurred on chromosome 5. Survival analysis showed that HBV integration was a risk factor for HCC recurrence (Hazard Ratio (HR): 3.366, P=0.019). However, there was no significant effect of HBV integration on the PFS after first-line systemic drug treatment (P=0.313). The overall survival of HCC patients with HBV integration was significantly shorter than their counterparts without HBV integration (HR (95% CI): 6.335 (1.237–32.446); P=0.027). Conclusion: HBV integration event was found to be a risk factor for HCC recurrence in HBV-HCC patients after radical surgery. Patients with HBV integration are potential candidates for active intervention in the early postoperative period.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews in Pharmacy and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews in Pharmacy and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Zixiong Li”
  • BylineArticles whose byline prints “Chao Chen”
  • BylineArticles whose byline prints “Anfeng Si”
  • BylineArticles whose byline prints “Wenshu Qu”
  • BylineArticles whose byline prints “Jue Zhang”
  • BylineArticles whose byline prints “Huiyu Li”
  • BylineArticles whose byline prints “Zhaojun Xia”
  • BylineArticles whose byline prints “Linhua Luo”